Operating revenue increases are impressive.Costs of product...

Operating revenue increases are impressive.

Costs of product development, innovation, staff and integration continue to dominate sales. At this stage these costs are necessary. This report gives confidence management are successfully pushing forward on several fronts.

Equally it will be important for management take opportunities for operating cost savings as we finalise integration and technology upgrades.

With 70m electronic customers and growing rapidly the opportunities for additional partnerships with pharma companies are exciting.

For me good value at this price

All IMO DYOR